Harrison Pharma Machinery Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.30 M
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -19.67%
- Profit Growth 48.48%
- Ebitda -100.37%
- Net Worth 14.23%
- Total Assets -32.26%
About Harrison Pharma Machinery
Harrison Pharma Machinery Private Limited (HPMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 1996 and has a history of 28 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Ahuja, Vrinda Ahuja, and Vani Ahuja serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51504DL1996PTC077174
-
Company No.
077174
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Mar 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Harrison Pharma Machinery Private Limited offer?
Harrison Pharma Machinery Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Laboratory Plates, Laboratory & Lab Equipment, Distilling Apparatus, Measuring Equipments & Instruments, Digital Counters, Laboratory Bath, Moisture Meter, Dinnerware and Serving Utensils, Water Jugs.
Who are the key members and board of directors at Harrison Pharma Machinery?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vani Ahuja | Additional Director | 27-Oct-2016 | Current |
Neeraj Ahuja | Director | 14-Mar-1996 | Current |
Vrinda Ahuja | Director | 31-Mar-2011 | Current |
Financial Performance of Harrison Pharma Machinery.
Harrison Pharma Machinery Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.67% decrease. The company also saw a substantial improvement in profitability, with a 48.48% increase in profit. The company's net worth Soared by an impressive increase of 14.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Harrison Pharma Machinery?
In 2022, Harrison Pharma Machinery had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Harrison Pharma Machinery?
Unlock and access historical data on people associated with Harrison Pharma Machinery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harrison Pharma Machinery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harrison Pharma Machinery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.